Company
Kanglin Biotechnology (Hangzhou) Co., Ltd.
Kanglin Biotechnology (Hangzhou) Co., Ltd. has 1 drug tracked on RxWires: 1 in Phase 1/2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| Injecting KL002 into the bilateral putamen | Phase 1/2 | Parkinson's Disease (PD) |
Latest
No recent events.
Follow Kanglin Biotechnology (Hangzhou) Co., Ltd. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.